22 May 2013
Keywords: ph, iii, salmon, calcitonin, trial, completes, recruitment
Article | 11 August 2008
Swiss drug major Novartis has finished recruitment into a multicenter Phase III study exploring the safety and efficacy of salmon ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
11 August 2008
21 May 2013
© 2013 thepharmaletter.com